Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.39 |
| ▸ | PRKDC | P78527 | 8/20 | 0.37 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25879127 | 1.00 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL25501083 | 0.91 | ALOX5 (0.37) | ALOX5GGPS1PRKDCPTGES2 | |
| SCHEMBL25878461 | 0.90 | ALOX5 (0.46) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL25879031 | 0.89 | ALOX5 (0.43) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL23614129 | 0.89 | ALOX5 (0.39) | ALOX5GGPS1PRKDCPTGES2 | |
| SCHEMBL25878359 | 0.89 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2PRMT5 | |
| SCHEMBL25878385 | 0.88 | ALOX5 (0.35) | ALOX5GGPS1PRKDCPDK2PLA2G2A | |
| SCHEMBL25878471 | 0.87 | ALOX5 (0.35) | ALOX5GGPS1PLA2G2APLA2G4A | |
| SCHEMBL25878945 | 0.87 | ALOX5 (0.36) | ALOX5GGPS1PRKDCPDK2PLA2G2A | |
| SCHEMBL25878451 | 0.87 | ALOX5 (0.39) | ALOX5GGPS1PRKDCPTGES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192669-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230192669-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192669-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | ACHE, OR51E2, L1CAM | ALOX5 1072/4885GGPS1 526/4885PRKDC 1991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.